Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-25-001158

Options or other derivatives

  • Chief Commercial Officer acquired 123,518 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rangarao Sai · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-07-02 Grant or award : show line 1 in the form Restricted Stock Units +30,518 30,518 D
2025-07-02 Grant or award : show line 2 in the form Stock Option +93,000 93,000 D
Loading xslF345X05/ownership.xml…